{"schema_version":"1","generated_at":"2026-11-08T23:34:28.041Z","data_as_of":null,"url":"https://www.findmykol.com/kol/maria-diab","json_url":"https://www.findmykol.com/kol/maria-diab/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"maria-diab","name":"Maria Diab","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Henry Ford Health","institution_url":"https://www.findmykol.com/institution/henry-ford-health","city":"Detroit","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1003259045","orcid":"0000-0002-4809-9535","openalex":"A5085875893"},"summary":"Maria Diab is a Hematology physician affiliated with Henry Ford Health. OpenAlex indexes 72 publications with 2,448 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":72,"cited_by_count":2448,"h_index":13,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03095781","title":"Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Emory University","source_url":"https://clinicaltrials.gov/study/NCT03095781","trial_url":"https://www.findmykol.com/trial/NCT03095781"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":20,"shown":3,"withheld":17,"rows":[{"payer":"Gilead","program_year":2025,"amount_usd":197188.14,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003259045"},{"payer":"Jazz Pharmaceuticals","program_year":2025,"amount_usd":42800,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003259045"},{"payer":"GSK","program_year":2025,"amount_usd":38050,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1003259045"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1003259045","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Outcomes with adjuvant chemotherapy in patients with early-stage biliary tract cancers: An NCDB analysis.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16302","status":"verified"},{"title":"Sacituzumab govitecan in combination with capecitabine for the treatment of advanced gastrointestinal cancers after progression on standard therapy.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.tps4271","status":"verified"},{"title":"Real-world outcomes in gastrointestinal cancer patients with targetable genomic alterations identified on serial liquid biopsy.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.4238","status":"verified"},{"title":"Outcomes of combined HCC-cholangiocarcinoma with adjuvant chemotherapy: An NCDB cohort.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.4166","status":"verified"},{"title":"TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors","year":2025,"journal":"Cell Reports Medicine","source_url":"https://doi.org/10.1016/j.xcrm.2025.102041","status":"verified"}],"source":"works"},"contact":{"address_1":"2799 W GRAND BLVD","city":"Detroit","state":"MI","zip":"482022608","phone":"800-653-6568","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1003259045","source":"identity"},"similar":[{"name":"Philip Philip","slug":"philip-philip","institution":"Henry Ford Health","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/philip-philip","json_url":"https://www.findmykol.com/kol/philip-philip/profile.json"},{"name":"David Lanfear","slug":"david-lanfear","institution":"Henry Ford Health","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/david-lanfear","json_url":"https://www.findmykol.com/kol/david-lanfear/profile.json"},{"name":"David Ozog","slug":"david-ozog","institution":"Henry Ford Health","specialty":"MOHS-Micrographic Surgery","url":"https://www.findmykol.com/kol/david-ozog","json_url":"https://www.findmykol.com/kol/david-ozog/profile.json"},{"name":"Jessica Mellinger","slug":"jessica-mellinger","institution":"Henry Ford Health","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/jessica-mellinger","json_url":"https://www.findmykol.com/kol/jessica-mellinger/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":17,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-12-22","provider_certified":"2022-12-22","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}